Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study

OBJECTIVE: To assess the effect of a 4-week adjunctive therapy of exenatide (EXE) (5–10 μg b.i.d.) or sitagliptin (SITA) (100 mg once daily) in response to a standardized breakfast meal challenge in 48 men or women with type 2 diabetes receiving insulin glargine (GLAR) + metformin (MET). RESEARCH DE...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Arnolds, Sabine, Dellweg, Sibylle, Clair, Janina, Dain, Marie-Paule, Nauck, Michael A., Rave, Klaus, Kapitza, Christoph
פורמט: Artigo
שפה:Inglês
יצא לאור: American Diabetes Association 2010
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890351/
https://ncbi.nlm.nih.gov/pubmed/20357372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-2191
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים